EQUIFAX INC — Director's Dealing 2020

Feb 25, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EQUIFAX INC (EFX)
CIK: 0000033185
Period of Report: 2020-02-21

Reporting Person: Hartman John T. (Pres-International)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-21	Common Stock	A	1567.0000	$0.0000	Acquired	20645.0000	Direct
2020-02-21	Common Stock	S	144.0000	$159.8300	Disposed	20501.0000	Direct
2020-02-21	Common Stock	S	222.0000	$160.4800	Disposed	20279.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-21	Stock Option/Right to Buy	$191.4400	A	6904.0000	Acquired	2026-02-21	Common Stock (6904.0000)	Direct
2020-02-21	Stock Option/Right to Buy	$175.4800	A	5472.0000	Acquired	2026-02-21	Common Stock (5472.0000)	Direct

Footnotes

F1: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/21/2023.

F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2019.

F4: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $159.15 to $160.14, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F5: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $160.16 to $160.60, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F6: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/21/2021.